Hangzhou Tigermed Consulting 

$10.16
2
+$0+0% Thursday 12:04

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
8.75B
P/E Ratio
-
Dividend Yield
0.41%
Dividend
0.04

Upcoming

Dividends

0.41%Dividend Yield
Jul 25
$0.04
Jul 24
$0.08
Jul 23
$0.08
Jun 22
$0.07
Jun 21
$0.05
10Y Growth
N/A
5Y Growth
-2.38%
3Y Growth
-19.28%
1Y Growth
N/A

Earnings

28AprExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
0.2
0.4
0.61
0.81
Expected EPS
0.35150166911999997
Actual EPS
N/A

Financials

6.37%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.78BRevenue
113.29MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HTMDF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Show more...
CEO
Country
US
ISIN
CNE1000040M1

Listings

0 Comments

Share your thoughts

FAQ

What is Hangzhou Tigermed Consulting stock price today?
The current price of HTMDF is $10.16 USD — it has increased by +0% in the past 24 hours. Watch Hangzhou Tigermed Consulting stock price performance more closely on the chart.
What is Hangzhou Tigermed Consulting stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hangzhou Tigermed Consulting stocks are traded under the ticker HTMDF.
What is Hangzhou Tigermed Consulting market cap?
Today Hangzhou Tigermed Consulting has the market capitalization of 8.75B
When is the next Hangzhou Tigermed Consulting earnings date?
Hangzhou Tigermed Consulting is going to release the next earnings report on April 28, 2026.
What were Hangzhou Tigermed Consulting earnings last quarter?
HTMDF earnings for the last quarter are 0.1 USD per share, whereas the estimation was 0.05 USD resulting in a +117.26% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Hangzhou Tigermed Consulting revenue for the last year?
Hangzhou Tigermed Consulting revenue for the last year amounts to 1.78B USD.
What is Hangzhou Tigermed Consulting net income for the last year?
HTMDF net income for the last year is 113.29M USD.
Does Hangzhou Tigermed Consulting pay dividends?
Yes, HTMDF dividends are paid annual. The last dividend per share was 0.04 USD. As of today, Dividend Yield (FWD)% is 0.41%.
When did Hangzhou Tigermed Consulting complete a stock split?
Hangzhou Tigermed Consulting has not had any recent stock splits.